ArticleHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2008

Reduction of Cardiovascular Risk through Angiotensin II Type 1 Receptor Antagonism : Focus on Olmesartan Medoxomil.

Enrico Agabiti RoseiPubMed ↗Publisher ↗

No numbers read from the abstract.